Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study by Nianmin Shi, Anvar Rasuli, Yaël Thollot

Get full text

Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric by Catherine Bravo, Larissa Mege, Claire Vigne, Yael Thollot

Get full text

Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015 by HeeSoo Kim, Yongho Oh, Yael Thollot, Catherine Bravo

Get full text

Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina by Carlos Espul, Laura Benedetti, Mariela Linares, Hector Cuello, Ivana Lo Castro, Yaël Thollot, Anvar Rasuli

Get full text

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C... by Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster

Get full text

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial by Lina Cordero De Los Santos, Jesús Feris-Iglesias, Naveena Aloysia D'Cor, Venkata Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Anvar Rasuli, Eric Desauziers

Get full text

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines by Maria Rosario Z. Capeding, Maria Liza Antoinette M. Gonzales, Mandeep Singh Dhingra, Naveena Aloysia D'Cor, Venkat Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Eric Desauziers

Get full text